Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

NCT00928018 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

139

Enrollment

OTHER

Sponsor class

Conditions

Non-hodgkin Lymphoma
Hodgkin Lymphoma

Interventions

DRUG: Sirolimus
DRUG: Methotrexate
DRUG: Tacrolimus
DRUG: Cyclosporine
DRUG: MMF

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]